Wageningen, Netherlands

Harm Gruppen

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Genencor International, Inc.. Active years: 2019.

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Harm Gruppen: Innovator in Enzymatic Activity for Xylan Degradation

Introduction

Harm Gruppen is a notable inventor based in Wageningen, Netherlands. He has made significant contributions to the field of enzymatic activity, particularly in the degradation and modification of xylan, a component of hemicellulose.

Latest Patents

Harm Gruppen holds a patent titled "Enzymatic activity of lytic polysaccharide monooxygenase." This invention focuses on enzymes that facilitate the degradation and modification of xylan. The patent describes a newly discovered enzymatic activity of lytic polysaccharide monooxygenases (LPMOs), which includes oxidative cleavage of xylan in addition to cellulose. The invention outlines methods for degrading and modifying xylan in substrates, as well as the preparation of products from xylan-comprising substrates.

Career Highlights

Harm Gruppen is associated with Genencor International, Inc., where he has been instrumental in advancing research related to enzymatic processes. His work has implications for various applications in biotechnology and materials science.

Collaborations

Harm has collaborated with notable colleagues, including Martijn Johannes Koetsier and Jacob B Visser, contributing to the advancement of research in enzymatic activity.

Conclusion

Harm Gruppen's innovative work in enzymatic activity for xylan degradation showcases his expertise and commitment to advancing biotechnology. His contributions are paving the way for new applications in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…